Igor Shapiro

Zurich, ZH 8091, Switzerland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

GSK3i combinatorial treatments affect CDK4/6 and compensatory pathways in 3D preclinical models of pancreatic neuroendocrine tumors.

GSK3i combinatorial treatments affect CDK4/6 and compensatory pathways in 3D preclinical models of pancreatic neuroendocrine tumors.

Journal: Biology open

Published: November 18, 2025

A novel 2D and 3D model for primary adrenocortical carcinoma of advanced and metastasized stage co-secreting cortisol, aldosterone, testosterone, 18-oxocortisol and 18-hydroxycortisol.

A novel 2D and 3D model for primary adrenocortical carcinoma of advanced and metastasized stage co-secreting cortisol, aldosterone, testosterone, 18-oxocortisol and 18-hydroxycortisol.

Journal: Endocrine-related cancer

Published: September 24, 2025

Anti-tumor potential of combinatory GSK3 inhibition in human 3D models of pancreatic neuroendocrine tumors and patient-derived GEP-NET primary cultures.

Anti-tumor potential of combinatory GSK3 inhibition in human 3D models of pancreatic neuroendocrine tumors and patient-derived GEP-NET primary cultures.

Journal: Endocrine-related cancer

Published: March 07, 2025

(Non)canonical Wnt signaling, cytoarchitecture and stemness: new insights from primary nonmetastatic, primary metastatic, regional and distant metastatic models of adrenocortical carcinoma.

(Non)canonical Wnt signaling, cytoarchitecture and stemness: new insights from primary nonmetastatic, primary metastatic, regional and distant metastatic models of adrenocortical carcinoma.

Journal: Experimental & molecular medicine

Published: December 30, 2024

The Vault Complex Is Significantly Involved in Therapeutic Responsiveness of Endocrine Tumors and Linked to Autophagy under Chemotherapeutic Conditions.

The Vault Complex Is Significantly Involved in Therapeutic Responsiveness of Endocrine Tumors and Linked to Autophagy under Chemotherapeutic Conditions.

Journal: Cancers

Published: February 20, 2023

Innovative multidimensional models in a high-throughput-format for different cell types of endocrine origin.

Innovative multidimensional models in a high-throughput-format for different cell types of endocrine origin.

Journal: Cell death & disease

Published: April 14, 2022

Novel Insights into the Molecular Regulation of Ribonucleotide Reductase in Adrenocortical Carcinoma Treatment.

Novel Insights into the Molecular Regulation of Ribonucleotide Reductase in Adrenocortical Carcinoma Treatment.

Journal: Cancers

Published: June 07, 2021

Targeting heterogeneity of adrenocortical carcinoma: Evaluation and extension of preclinical tumor models to improve clinical translation.

Targeting heterogeneity of adrenocortical carcinoma: Evaluation and extension of preclinical tumor models to improve clinical translation.

Journal: Oncotarget

Published: August 16, 2016

Characterization of NCI-H295R cells as an in vitro model of hyperaldosteronism.

Characterization of NCI-H295R cells as an in vitro model of hyperaldosteronism.

Journal: Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme

Published: November 01, 2012

The side population phenomenon enriches for designated adrenocortical progenitor cells in mice.

The side population phenomenon enriches for designated adrenocortical progenitor cells in mice.

Journal: The Journal of endocrinology

Published: October 09, 2012

Showing 1-10 of 10

Last Updated: 09/26/2026